SCHEMBL21136775

SCHEMBL21136775

CC(C)(C)OC(=O)N1CCN(c2c([N+](=O)[O-])cnc3cc(Br)c(Cl)cc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.47
KCNH2 Q12809 1/20 0.46
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
MAPK8 P45983 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
MAPK1 P28482 1/20 0.38
PGK1 P00558 1/20 0.37
POLB P06746 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
PDGFRB P09619 1/20 0.37
CYP8B1 Q9UNU6 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136848 0.88 MET (0.47) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21137056 0.86 GPR119 (0.41) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21136722 0.85 MAP4K4 (0.42) METKCNH2MAPTMAPK8POLB
SCHEMBL21099361 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21137316 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21100021 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21099607 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21099203 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21050822 0.85 MET (0.39) METKCNH2ALDH1A1LMNAMAPT
SCHEMBL21136735 0.84 KCNH2 (0.47) METKCNH2ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed